Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
2016 1
2017 2
2018 3
2021 2
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab.
Minohara K, Matoba T, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Hojo W, Matsumura A, Ozaki S, Ozawa T, Harata I, Tanaka N, Maseki S, Tsuge H, Imaizumi S, Mitsuya S, Moribe K, Esaki S, Iwasaki S. Minohara K, et al. Among authors: hojo w. Sci Rep. 2021 Aug 20;11(1):16992. doi: 10.1038/s41598-021-96538-7. Sci Rep. 2021. PMID: 34417539 Free PMC article.
Iron-heme-Bach1 axis is involved in erythroblast adaptation to iron deficiency.
Kobayashi M, Kato H, Hada H, Itoh-Nakadai A, Fujiwara T, Muto A, Inoguchi Y, Ichiyanagi K, Hojo W, Tomosugi N, Sasaki H, Harigae H, Igarashi K. Kobayashi M, et al. Among authors: hojo w. Haematologica. 2017 Mar;102(3):454-465. doi: 10.3324/haematol.2016.151043. Epub 2016 Dec 7. Haematologica. 2017. PMID: 27927768 Free PMC article.
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer.
Funakoshi Y, Yakushijin K, Ohji G, Hojo W, Sakai H, Takai R, Nose T, Ohata S, Nagatani Y, Koyama T, Kitao A, Nishimura M, Imamura Y, Kiyota N, Harada K, Tanaka Y, Mori Y, Minami H. Funakoshi Y, et al. Among authors: hojo w. J Infect Chemother. 2022 Apr;28(4):516-520. doi: 10.1016/j.jiac.2021.12.021. Epub 2021 Dec 30. J Infect Chemother. 2022. PMID: 35090826 Free PMC article.
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
Funakoshi Y, Yakushijin K, Ohji G, Hojo W, Sakai H, Watanabe M, Saeki M, Hirakawa Y, Sakai R, Matsumoto S, Mizutani Y, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Nishimura M, Imamura Y, Kiyota N, Matsuoka H, Mori Y, Minami H. Funakoshi Y, et al. Among authors: hojo w. Int J Hematol. 2022 Jan;115(1):7-10. doi: 10.1007/s12185-021-03247-y. Epub 2022 Jan 4. Int J Hematol. 2022. PMID: 34981433 Free PMC article.
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation.
Watanabe M, Yakushijin K, Funakoshi Y, Ohji G, Hojo W, Sakai H, Saeki M, Hirakawa Y, Matsumoto S, Sakai R, Nagao S, Kitao A, Miyata Y, Koyama T, Saito Y, Kawamoto S, Ito M, Murayama T, Matsuoka H, Minami H. Watanabe M, et al. Among authors: hojo w. Vaccines (Basel). 2022 Jan 21;10(2):158. doi: 10.3390/vaccines10020158. Vaccines (Basel). 2022. PMID: 35214617 Free PMC article.
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination.
Funakoshi Y, Yakushijin K, Ohji G, Hojo W, Sakai H, Watanabe M, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Koyama T, Imamura Y, Kiyota N, Matsuoka H, Mori Y, Minami H. Funakoshi Y, et al. Among authors: hojo w. Vaccines (Basel). 2022 Jun 17;10(6):965. doi: 10.3390/vaccines10060965. Vaccines (Basel). 2022. PMID: 35746573 Free PMC article.
Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors.
Matoba T, Minohara K, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Tsuge H, Tanaka N, Imaizumi S, Hojo W, Matsumura A, Tsukamoto K, Esaki S, Iwasaki S. Matoba T, et al. Among authors: hojo w. Sci Rep. 2022 Aug 22;12(1):14319. doi: 10.1038/s41598-022-18611-z. Sci Rep. 2022. PMID: 35996017 Free PMC article.
12 results